In summary, this study explored the inhibitory effect of SD on the malignant phenotype of GC cells, which may be due to SD targeting the ERBB2/ERBB3/PI3K/AKT pathway, using network pharmacology and cell experiments. The gene discussed is ERBB2; the disease is gastric cancer.